Tectonic Therapeutic Inc. Live Share Price Today, Share Analysis and Chart

Name: Tectonic Therapeutic Inc.: Is Infosys Ltd. worth buying?
Item: Tectonic Therapeutic Inc.
Rating: 1.39075
Author: Trendlyne DVM scores

about

Avrobio Inc is a clinical-stage gene therapy company. The company is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single-dose treatment regimen. The company's pipeline includes AVR-RD...

22.64 0.92 (4.24%)

62.93% Fall from 52W High

382.4K

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

10.5 / 100

Technically Neutral

45.1 / 100

No estimates available

Tectonic Therapeutic Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tectonic Therapeutic Inc. Live Share Price Today, Share Analysis and Chart

Avrobio Inc is a clinical-stage gene therapy company. The company is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single-dose treatment regimen. The company's pipeline includes AVR-RD...

62.93% Fall from 52W High

SWOT Analysis

Tectonic Therapeutic Inc. Live Price Chart